Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson’s Drug Discovery
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1918
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson’s Drug Discovery ; volume:39 ; number:11 ; day:20 ; month:7 ; year:2019 ; pages:1067-1075 ; date:11.2019
Clinical drug investigation ; 39, Heft 11 (20.7.2019), 1067-1075, 11.2019
- Creator
-
Cepeda, M. Soledad
Kern, David M.
Seabrook, Guy R.
Lovestone, Simon
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40261-019-00830-4
- URN
-
urn:nbn:de:101:1-2020021420561992148774
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cepeda, M. Soledad
- Kern, David M.
- Seabrook, Guy R.
- Lovestone, Simon
- SpringerLink (Online service)
Other Objects (12)
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
Disease progression strikingly differs in research and real-world Parkinson’s populations
Microbial biomarker discovery in Parkinson’s disease through a network-based approach
Phenome-based gene discovery provides information about Parkinson’s disease drug targets
Impact of advanced Parkinson’s disease on caregivers: an international real-world study
Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota
Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry
Economic Burden of Parkinson’s Disease: A Multinational, Real-World, Cost-of-Illness Study
Real-world use of Safinamide in motor fluctuating Parkinson’s disease patients in Italy
Comprehensive real time remote monitoring for Parkinson’s disease using Quantitative DigitoGraphy
Automated Real-World Video Analysis of Sit-to-Stand Transitions Predicts Parkinson’s Disease Severity
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
Disease progression strikingly differs in research and real-world Parkinson’s populations
Microbial biomarker discovery in Parkinson’s disease through a network-based approach
Phenome-based gene discovery provides information about Parkinson’s disease drug targets
Impact of advanced Parkinson’s disease on caregivers: an international real-world study
Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota
Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry
Economic Burden of Parkinson’s Disease: A Multinational, Real-World, Cost-of-Illness Study
Real-world use of Safinamide in motor fluctuating Parkinson’s disease patients in Italy
Comprehensive real time remote monitoring for Parkinson’s disease using Quantitative DigitoGraphy
Automated Real-World Video Analysis of Sit-to-Stand Transitions Predicts Parkinson’s Disease Severity
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
Disease progression strikingly differs in research and real-world Parkinson’s populations
Microbial biomarker discovery in Parkinson’s disease through a network-based approach
Phenome-based gene discovery provides information about Parkinson’s disease drug targets
Impact of advanced Parkinson’s disease on caregivers: an international real-world study
Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota
Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry
Economic Burden of Parkinson’s Disease: A Multinational, Real-World, Cost-of-Illness Study
Real-world use of Safinamide in motor fluctuating Parkinson’s disease patients in Italy
Comprehensive real time remote monitoring for Parkinson’s disease using Quantitative DigitoGraphy